MedTrace Logo

Anti-ageing Efficacy of a Cosmetic Formulation Containing NMN (2%) Versus Placebo

NCT04685096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2021-04-23

No results posted yet for this study

Summary

The study aims at evaluating skin wrinkling, puffiness and fatigue and dark circle appearance on asian and african-american healthy volunteer cohorts receiving a cosmetic formulation containing NMN (2%). The product will be evaluated after 28 and 56 days of twice-daily application in comparison with a reference cosmetic formulation using clinical scoring under dermatological control. Cosmetic acceptability and future use will also be subjectively evaluated by analysis of the subjects answers to an evaluation questionnaire.

Conditions

  • Wrinkle
  • Fatigue
  • Puffiness Around the Eyes

Interventions

OTHER

Test product creme

twice daily application of creme containing 2% NMN

OTHER

Reference creme

twice daily application of reference creme

Sponsors & Collaborators

  • Eurofins

    collaborator INDUSTRY

  • LGD

    collaborator INDUSTRY

  • Seneque SA

    lead INDUSTRY

Principal Investigators

  • Corinne BENIER · Dermscan

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-12
Primary Completion
2021-03-12
Completion
2021-04-16

Countries

  • United States
  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04685096 on ClinicalTrials.gov